Novo Nordisk Pharmatech A/S mwvm@novonordisk.com https://novonordiskpharmatechas.twentythree.com en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Novo Nordisk Pharmatech A/S episodic no https://novonordiskpharmatechas.twentythree.com/files/rv1.4/sitelogo.gif https://novonordiskpharmatechas.twentythree.com http://novonordiskpharmatechas.twentythree.com/presentation-is-recombinant-insulin-1 <p>Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.<p></p> <p>Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production.</p></p><p><a href="http://novonordiskpharmatechas.twentythree.com/presentation-is-recombinant-insulin-1"><img src="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/standard/download-10-thumbnail.jpg" width="75" height=""/></a></p> http://novonordiskpharmatechas.twentythree.com/photo/85911246 Thu, 28 Oct 2021 00:00:00 GMT Presentation: Is recombinant Insulin a factor to consider viral production? Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre. Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production. Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre. Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes... Novo Nordisk Pharmatech A/S 17:18 <p>Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.<p></p> <p>Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production.</p></p><p><a href="http://novonordiskpharmatechas.twentythree.com/presentation-is-recombinant-insulin-1"><img src="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/standard/download-10-thumbnail.jpg" width="75" height=""/></a></p> growth factor Recombinant Insulin viral production